Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: An economic modelling exercise
Open accessAbstract
Background: The global burden of dementia is increasing. As diagnosis and treatment rates increase and populations grow and age, additional diagnosed cases will present a challenge to healthcare systems globally. Even modelled estimates of the current and future healthcare spending attributable to dementia are valuable for decision makers and advocates to prepare for growing demand. Methods: We modelled healthcare spending attributable to dementia from 2000 to 2019 and expected estimated future spending from 2020 to 2050 under multiple scenarios. Data were from the Global Burden of Diseases 2019 study and from two systematic literature reviews. We used meta-regression to estimate the fraction of dementia spending that is attributable to dementia for those receiving nursing home-based care and for those receiving community-based care. We used spatiotemporal Gaussian process regression to account for data missingness and model diagnosis and treatment rates, nursing home-based care and community-based care rates, and unit costs for the many countries without their own underlying estimates. Projections of future spending estimate a baseline scenario from 2020 to 2050 based on ongoing growth. Alternative scenarios assessed faster growth rates for dementia diagnosis and treatment rates, nursing home-based care, and healthcare costs. All spending is reported in 2019 United States dollars or 2019 purchasing-power parity-adjusted dollars. Findings: Based on observed and modelled inputs, we estimated that global spending on dementia increased by 4.5% (95% uncertainty interval: 3.4-5.4%) annually from 2000 to 2019, reaching $263 billion (95% uncertainty interval [UI] $199- $333) attributable to dementia in 2019. We estimated total healthcare spending on patients with dementia was $594 billion (95% UI $457-$843). Under the baseline scenario, we estimated that attributable dementia spending will reach $1.6 trillion (95% UI $0.9-$2.6) by 2050. We project it will represent 11% (95% UI 6-18%) of all expected health spending, although it could be as high as 17% (95% UI 10-26%) under alternative scenarios. Interpretation: Health systems will experience increases in the burden of dementia in the near future. These modelled direct cost estimates, built from a relatively small set of data and linear time trends, highlight the magnitude of health system resources expected to be used to provide care and ensure sufficient and adequate resources for aging populations and their caretakers. More data are needed to corroborate these important trends.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pedroza and colleagues estimated that $594 billion was spent worldwide on people living with dementia in 2019, with $263 billion being attributable to dementia.
“They estimated that $594 billion was spent worldwide on people living with dementia in 2019, with $263 billion being attributable to dementia.”
From Societal Costs of Dementia: 204 Countries, 2000–2019 (2024) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · see citing works
Self-citationNichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575 · see citing works
Self-citationKassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163 · see citing works
Self-citationVollset, S. E., Goren, E., Yuan, C.-W., Cao, J., Smith, A. E., Hsiao, T., Bisignano, C., Azhar, G. S., Castro, E., Chalek, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30677-2 · Cited by 1,506 · see citing works
Self-citationUS Health Care Spending by Payer and Health Condition, 1996-2016
Dieleman, J. L., Cao, J., Chapin, A., Chen, C., Li, Z., Liu, A., Horst, C., Kaldjian, A., Matyasz, T., Scott, K. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.0734 · Cited by 1,313 · see citing works
Self-citationThe cost of Alzheimer's disease in China and re‐estimation of costs worldwide
Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.12.006 · Cited by 752 · see citing works
Tom, S. E., Hubbard, R. A., Crane, P. K., Haneuse, S. J., Bowen, J., McCormick, W. C., McCurry, S., & Larson, E. B. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.301935 · Cited by 185 · see citing works
Flagged first, then by citations
Research works printed but not linked: 14
- [3]Livingston G. Sommerlad A. Orgeta V. Dementia prevention, intervention, and care Lancet 390 2017 2673 2734 28735855
- [5]Wimo A. Guerchet M. Ali G.C. The worldwide costs of dementia 2015 and comparisons with 2010 Alzheimers Dement 13 2017 1 7 27583652 PMC5232417
- [6]Hurd M.D. Martorell P. Langa K. Future monetary costs of dementia in the United States under alternative dementia prevalence scenarios J Popul Ageing 8 2015 101 112 25926904 PMC4410878
- [8]Sado M. Ninomiya A. Shikimoto R. The estimated cost of dementia in Japan, the most aged society in the world PLoS One 13 2018 e0206508 PMC6231619 30418983
- [11]Wimo A. Jönsson L. Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003 Dement Geriatr Cogn Disord 21 2006 175 181 16401889
- [12]Wimo A. Winblad B. Jönsson L. The worldwide societal costs of dementia: estimates for 2009 Alzheimers Dement 6 2010 98 103 20298969
- [13]Wimo A. Jönsson L. Bond J. Prince M. Winblad B. The worldwide economic impact of dementia 2010 Alzheimers Dement 9 2013 1 11 e3 23305821
- [14]Wimo A, Prince M. World Alzheimer report 2010 | The global economic impact of dementia. 2010. 23305821
- [17]Larson E.B. Yaffe K. Langa K.M. New insights into the dementia epidemic N Engl J Med 369 2013 2275 2277 24283198 PMC4130738
- [19]Murray C.J.L. Aravkin A.Y. Zheng P. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 396 2020 1223 1249 33069327 PMC7566194
- [21]GBD 2019 Demographics Collaborators Global, regional, and national age-sex-specific fertility, mortality, and population estimates, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 Lancet 2022 In Press PMC7566045 33069325
- [23]Viechtbauer W. Conducting meta-analyses in R with the metafor package J Stat Softw 36 2010 10.18637/jss.v036.i03 · DOI · Paper page
- [25]Vos T. Lim S.S. Abbafati C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 396 2020 1204 1222 33069326 PMC7567026
- [27]Global action plan on the public health response to dementia, 2017–2025. https://apps.who.int/iris/bitstream/handle/10665/259615/9789241513487-eng.pdf;jsessionid=9D02CCDE713EB5A59867E0B66AE19E70?sequence=1. Accessed 7 April 2020). 30600688
Cited by
Sorted by citations
Nandi, A., Counts, N., Chen, S., Seligman, B., Tortorice, D., Vigo, D., & Bloom, D. E. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101580 · Cited by 402 · see citing works
Social participation and risk of developing dementia
Sommerlad, A., Kivimäki, M., Larson, E. B., Röhr, S., Shirai, K., Singh-Manoux, A., & Livingston, G. (2023) · Nature Aging · doi:10.1038/s43587-023-00387-0 · Cited by 207 · see citing works
Societal Costs of Dementia: 204 Countries, 2000–2019
Lastuka, A., Bliss, E., Breshock, M. R., Iannucci, V. C., Sogge, W., Taylor, K. V., Pedroza, P., & Dieleman, J. L. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240163 · Cited by 41 · see citing works
Self-citationSommerlad, A., & Liu, K. Y. (2023) · BMJ · doi:10.1136/bmj.p655 · Cited by 18 · see citing works
- Authors
- Pedroza, P., Miller-Petrie, M. K., Chen, C., Chakrabarti, S., Chapin, A., Hay, S., Tsakalos, G., Wimo, A., & Dieleman, J. L.
- Affiliations
- University of Washington (US)
- Karolinska Institutet (SE)
- Corresponding author
- Dieleman, Joseph L
- Venue
- eClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 45
- Pages
- 101337
- ISSN
- 2589-5370 (ISSN-L)
- PMC
- PMC8921543
- OpenAlex
- W4221074325
- Cited by
- 177
- References
- 7
- Citations by year
- 2026: 23 · 2025: 42 · 2024: 70 · 2023: 34 · 2022: 8
- FWCI
- 25.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- EClinicalMedicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › General Health Professions › Global Health Care Issues
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- dementia care costs, nursing home care, community-based care, meta-regression, global burden of disease, health system preparedness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review